Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-31 to 2023-09-01
Current total value of award: $12934.05
Description: 4562009173!XITANDI 40MG GCAP 120S